Back to RecallTracker
Health Canada Health products

FLUOROQUINOLONES - Risk of Disabling and Persistent Serious Adverse Reactions

Issued January 23, 2017
Issue
Canadian and international cases of disabling and persistent serious adverse reactions including tendinopathy, peripheral neuropathy, and central nervous system disorders have been reported in patients treated with oral and injectable fluoroquinolones.
Hazard description
Product safety